CME Group price target raised to $299 from $283 at Barclays

Barclays raised the firm’s price target on CME Group (CME) to $299 from $283 and keeps an Equal Weight rating on the shares. Heading into the Q2 reports for the brokers, asset managers and exchanges, the firm says trading activity was “generally robust” through the quarter. The Federal funds rate remains supportive for net interest income through the rest of the year, the analyst tells investors in a research note. Barclays sees the trading environment as “fairly robust.”